Navigation Links
Study uncovers mechanism used by BRCA1 to suppress tumors
Date:12/17/2012

WASHINGTON -- A new study by Georgetown University Medical Center researchers reveals how a well-known tumor suppressor gene may be functioning to stop cancer cell growth.

The findings, published online today in Oncogene, focus on the gene BRCA1, which is mutated in a majority of families who have hereditary breast and/or ovarian cancers, according to senior author Ronit I. Yarden, PhD, assistant professor in the Department of Human Science at the School of Nursing & Health Studies.

"There is a debate in the scientific community about whether BRCA1 enzymatic activity is important in tumor suppressor function," Yarden said. "My lab thinks it is."

Previous research by other investigators, according to Yarden, has shown that BRCA1 is an ubiquitin E3 ligase enzyme. When added to other proteins, ubiquitin has the ability to mark them for degradation and recycling.

Her laboratory worked to discover which proteins BRCA1 is targeting with ubiquitin and how that activity might help attenuate cell division in response to DNA damage a function that is important for maintaining genomic integrity and suppressing tumor growth.

"Cells have surveillance mechanisms and check points that govern cell division," she said. "In order to conduct DNA repair in a timely fashion, a cell must be stopped for awhile and then repaired. Once DNA is fixed, division can then begin again."

Yarden's lab discovered that BRCA1 targets two specific proteins cyclin B and Cdc25c, which are the "keeper genes" that regulate the G2/M checkpoint the last checkpoint a cell has to go through before it divides.

"The paper shows that in response to DNA damage, BRCA1 is responsible for tagging these two proteins to stop the cells from dividing so repair can occur," Yarden said. "This work shows that BRCA1 enzymatic function is essential for maintaining genomic integrity and may explain BRCA1 role in tumor suppression."

"We identified a novel function," she said. "Although different substrates for BRCA1 were previously identified by other investigators, those didn't explain directly BRCA1's role in maintenance of genomic integrity. Our new targets are the first to directly link this ubiquitination function of BRCA1 to halting cell division that is important for maintenance of genomic integrity and stability, an important activity of tumor suppression."


'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
Georgetown University Medical Center
Source:Eurekalert

Related biology news :

1. Penn Study shows resistance to cocaine addiction may be passed down from father to son
2. Study confirms prognostic value of new IASLC/ATS/ERS adenocarcinoma sub-classification
3. Study shows immunohistochemistry is reliable screening tool for ALK rearrangement
4. Study fuels insight into conversion of wood to bio-oil
5. Warming climate unlikely to cause extinction of ancient Amazon trees, study finds
6. University of Illinois receives grant to study ozone resistance in corn
7. OU study suggests the bacterial ecology that lives on humans has changed in the last 100 years
8. Study sheds light on how cells transport materials along crowded intercellular highways
9. Scientists develop novel method to study parasite numbers in wild seabirds
10. Mercyhurst University study probes impact of climate change on ectotherms
11. U of M to lead international virtual institute studying climatic and human effects on Earth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... ... October 08, 2019 , ... ... are announcing a collaboration with the National Research Council of Canada (NRC) ... knowledge in nanofabrication and lab-on-a-chip technologies and in manufacturing, LIFT will offer ...
(Date:10/8/2019)... ... October 07, 2019 , ... The future of medicine in the 21st century ... people living longer, healthier lives. But it will be up to each individual to ... MD, PhD, Chief Strategy Officer and Co-Founder of the Institute for Systems Biology and ...
(Date:10/3/2019)... ... October 01, 2019 , ... The ... chemicals, reagents, and medias and to be a more environmentally sustainable evolution to ... of years of experience and feedback from the original version we launched in ...
Breaking Biology News(10 mins):
(Date:9/24/2019)... WEST LAFAYETTE, Ind. (PRWEB) , ... ... ... Pharma LLC will be presenting their latest research in the area of ... Monday, November 4th, Dr. Pamela Smith, COO of Improved Pharma, will present ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... company, has completed training and site qualification for clinical trial sites and physician ... and screening of potential clinical trial participants. , Clinical trial sites are currently ...
(Date:9/22/2019)... ... September 20, 2019 , ... ... Brain-Derived Neurotrophic Factor (BDNF) testing in serum . BDNF plays a vital ... stimulates the growth and differentiation of new neurons in the brain involved in ...
(Date:9/17/2019)... (PRWEB) , ... September 17, 2019 , ... ... to improve success in chronic diseases, announces today that the U.S. Patent and ... multi-gene combinatorial genetic algorithm to rank drug class recommendations for hypertension treatment. ...
Breaking Biology Technology: